| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.70B | 27.75B | 27.01B | 20.37B | 6.82B | 2.83B |
| Gross Profit | 5.15B | 4.26B | 2.65B | 2.45B | 254.98M | 302.15M |
| EBITDA | 3.62B | 2.70B | 2.51B | 1.51B | 442.29M | 250.81M |
| Net Income | 808.17M | 591.20M | 294.38M | 691.63M | 140.03M | 5.16M |
Balance Sheet | ||||||
| Total Assets | 130.54B | 122.47B | 105.43B | 90.46B | 38.62B | 18.30B |
| Cash, Cash Equivalents and Short-Term Investments | 11.25B | 10.89B | 7.98B | 11.11B | 9.29B | 4.30B |
| Total Debt | 52.53B | 46.22B | 29.25B | 17.82B | 2.92B | 1.11B |
| Total Liabilities | 81.73B | 74.42B | 59.04B | 48.89B | 13.63B | 5.69B |
| Stockholders Equity | 35.65B | 35.18B | 34.65B | 34.38B | 29.56B | 14.42B |
Cash Flow | ||||||
| Free Cash Flow | -10.74B | -13.49B | -17.23B | -33.50B | -11.13B | -1.50B |
| Operating Cash Flow | 2.47B | 3.11B | 2.90B | 3.28B | 2.01B | 2.15B |
| Investing Cash Flow | -15.04B | -18.28B | -19.93B | -24.00B | -15.01B | -5.26B |
| Financing Cash Flow | 6.15B | 16.39B | 13.90B | 29.76B | 14.84B | 4.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.43B | 8.32 | 8.98% | 6.40% | 13.14% | -28.26% | |
72 Outperform | HK$27.76B | 14.82 | 17.75% | 2.24% | 20.33% | 27.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$1.31B | 12.35 | 19.99% | ― | 11.61% | 287.50% | |
61 Neutral | HK$58.49B | 27.82 | 2.28% | ― | 16.36% | 102.93% | |
48 Neutral | HK$471.32M | -1.78 | -16.83% | ― | -28.40% | -350.00% | |
40 Underperform | HK$192.47M | -7.46 | -6.18% | ― | -0.84% | 42.31% |